Bausch + Lomb [BLCO] vs Repligen [RGEN] Detailed Stock Comparison

Bausch + Lomb Corporation

NYSE
Loading...

Repligen Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bausch + Lomb Corporation wins in 13 metrics, Repligen Corporation wins in 6 metrics, with 0 ties. Bausch + Lomb Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bausch + Lomb Corporation Repligen Corporation Better
P/E Ratio (TTM) N/A 154.30 N/A
Price-to-Book Ratio 0.87 3.55 Bausch + Lomb Corporation
Debt-to-Equity Ratio 80.46 32.76 Repligen Corporation
PEG Ratio 15.00 -1.10 Bausch + Lomb Corporation
EV/EBITDA 17.30 59.13 Bausch + Lomb Corporation
Profit Margin (TTM) -7.06% 6.62% Repligen Corporation
Operating Margin (TTM) 11.25% 8.26% Bausch + Lomb Corporation
EBITDA Margin (TTM) 11.25% 8.26% Bausch + Lomb Corporation
Return on Equity -5.39% 2.40% Repligen Corporation
Return on Assets (TTM) 0.86% 0.99% Repligen Corporation
Free Cash Flow (TTM) $-66.00M $91.69M Repligen Corporation
1-Year Return 36.44% 4.98% Bausch + Lomb Corporation
Price-to-Sales Ratio (TTM) 1.11 10.14 Bausch + Lomb Corporation
Enterprise Value $10.54B $7.36B Bausch + Lomb Corporation
EV/Revenue Ratio 2.07 9.97 Bausch + Lomb Corporation
Gross Profit Margin (TTM) 62.06% 52.46% Bausch + Lomb Corporation
Revenue per Share (TTM) $14 $13 Bausch + Lomb Corporation
Earnings per Share (Diluted) $-1.02 $0.86 Repligen Corporation
Beta (Stock Volatility) 0.65 1.19 Bausch + Lomb Corporation
Short % of Float 8.28% 9.88% Bausch + Lomb Corporation

Bausch + Lomb Corporation vs Repligen Corporation Stock Performance Analysis

Loading Price Chart...

BLCO
RGEN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bausch + Lomb Corporation3.23%-1.54%-5.83%-14.96%-8.69%-7.42%
Repligen Corporation3.96%3.11%7.06%0.56%-23.65%-23.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bausch + Lomb Corporation36.44%-14.25%107.84%147.63%62.85%62.85%
Repligen Corporation4.98%-25.89%-30.28%399.40%3,170.45%3,773.44%

Performance & Financial Health Analysis: Bausch + Lomb Corporation vs Repligen Corporation

MetricBLCORGEN
Market Information
Market Cap i$5.64B$7.49B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i346,920734,741
90 Day Avg. Volume i406,820871,350
Last Close$15.35$126.55
52 Week Range$11.44 - $18.92$100.99 - $175.77
% from 52W High-18.85%-28.00%
All-Time High$21.95 (Jun 26, 2023)$327.32 (Sep 20, 2021)
% from All-Time High-30.07%-61.34%
Growth Metrics
Quarterly Revenue Growth0.10%0.18%
Quarterly Earnings Growth0.10%0.18%
Financial Health
Profit Margin (TTM) i-0.07%0.07%
Operating Margin (TTM) i0.11%0.08%
Return on Equity (TTM) i-0.05%0.02%
Debt to Equity (MRQ) i80.4632.76
Cash & Liquidity
Book Value per Share (MRQ)$18.20$37.39
Cash per Share (MRQ)$1.08$13.63
Operating Cash Flow (TTM) i$283.00M$117.42M
Levered Free Cash Flow (TTM) i$141.38M$76.07M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Bausch + Lomb Corporation vs Repligen Corporation

MetricBLCO (Apr 26, 2026)RGEN (Apr 21, 2026)
Price Ratios
P/E Ratio (TTM) iN/A154.30
Forward P/E i15.0052.71
PEG Ratio i15.00-1.10
Price to Sales (TTM) i1.1110.14
Price to Book (MRQ) i0.873.55
Market Capitalization
Market Capitalization i$5.64B$7.49B
Enterprise Value i$10.54B$7.36B
Enterprise Value Metrics
Enterprise to Revenue i2.079.97
Enterprise to EBITDA i17.3059.13
Risk & Other Metrics
Beta i0.651.19
Book Value per Share (MRQ) i$18.20$37.39

Financial Statements Comparison: Bausch + Lomb Corporation vs Repligen Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBLCO (2025)RGEN (2025)
Revenue/Sales i5.10B738.26M
Cost of Goods Sold i2.05B352.01M
COGS % of Revenue i40.2%47.7%
Gross Profit i3.05B386.25M
Gross Margin i59.8%52.3%
Research & Development i371.00M54.18M
Operating Income (EBIT) i188.00M41.56M
Operating Margin i3.7%5.6%
EBITDA i621.00M139.67M
EBITDA Margin i12.2%18.9%
Pre-Tax Income i-317.00M62.38M
Pre-Tax Income % of Revenue i-6.2%8.5%
Income Tax i35.00M13.49M
Income Tax % of Revenue i0.7%1.8%
Net Income (Profit) i-352.00M48.89M
Profit Margin i-6.9%6.6%

Balance Sheet & Liquidity Metrics

MetricBLCO (2025)RGEN (2025)
Cash & Equivalents i383.00M566.02M
Total Current Assets i2.98B1.14B
Total Current Assets % of Revenue i58.4%154.1%
Total Current Liabilities i1.92B135.83M
Total Current Liabilities % of Revenue i37.6%18.4%
Long-Term Debt i5.04B668.39M
Long-Term Debt % of Revenue i98.9%90.5%
Total Shareholders Equity i6.52B2.11B
Retained Earnings i-931.00M456.25M
Retained Earnings % of Revenue i-18.3%61.8%
Property, Plant & Equipment i0267.49M

Cash Flow Statement Comparison

MetricBLCO (2025)RGEN (2025)
Operating Cash Flow i240.00M113.36M
Operating Cash Flow % of Revenue i4.7%15.4%
Capital Expenditures i-349.00M-23.28M
Free Cash Flow i-66.00M91.69M
FCF Margin i-1.3%12.4%
Debt Repayment i-3.10B0
Common Stock Repurchase iN/A0

Short Interest & Institutional Ownership Analysis

MetricBLCORGEN
Shares Short i3.71M5.56M
Short Ratio i8.996.38
Short % of Float i8.28%9.88%
Shares Outstanding i354.21M56.33M
Float Shares i44.54M53.30M
% Held by Insiders i87.57%5.29%
% Held by Institutions i11.53%112.70%
% Held by Public i0.90%-17.99%

Dividend Analysis & Yield Comparison: Bausch + Lomb Corporation vs Repligen Corporation

MetricBLCORGEN
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A